Marijuana Use, Strength Training, and Alcohol Consumption (MUSTAC) Study

July 5, 2023 updated by: University of Florida
Self-medication of pain by consuming alcohol and marijuana is common. However, the research regarding pain as a determinant for alcohol and marijuana use has relied on laboratory pain induction paradigms with limited clinical relevance. The study will assess demand for alcohol and marijuana before and after delayed onset muscle soreness (DOMS) induction in co-users. This will provide a clinically relevant, but time-limited, model for the effects of musculoskeletal pain on demand.

Study Overview

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • University of Florida Center for Pain Research and Behavioral Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age ≥ 21 years;
  • English-speaking
  • Self-identify as White/Caucasian or Black/African American
  • Own a smartphone with cellular/data plan
  • Regularly co-use alcohol and smoked marijuana as indicated by scores of ≥3 on item 1 of the CUDIT-R and AUDIT.
  • Willing and able to give informed consent

Exclusion Criteria:

  • Participation in biceps-specific conditioning program in the past 6 months*
  • Self-reported wrist/hand, elbow, or shoulder pain the past 3 months
  • Chronic medical condition that may affect pain perception (e.g. diabetes, fibromyalgia, headaches)
  • Self-reported kidney dysfunction, muscle damage, or major psychiatric disorder
  • Medical marijuana prescription
  • Consumption of marijuana using only non-inhalational methods (e.g. edibles, tinctures, or cannabidiol oil)
  • Score of ≥ 10 on Patient Health Questionnaire-9 (moderate depression)
  • Women who are pregnant, trying to become pregnant, or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Delayed Onset Muscle Soreness Induction
Participants will complete an exercise session designed to induce delayed onset muscle soreness in the biceps
Muscle lengthening biceps exercise
Sham Comparator: Sham Delayed Onset Muscle Soreness Induction
Participants will complete an exercise session that is unlikely to induce delayed onset muscle soreness in the biceps
Muscle shortening biceps exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol Demand: Breakpoint
Time Frame: 48 hours after exercise
Changes in breakpoint of alcohol demand, assessed using the Alcohol Purchase Task. Breakpoint indicates the drink price at which participants report no alcohol consumption. Values represent difference scores derived from breakpoint values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Alcohol Demand: Omax
Time Frame: 48 hours after exercise
Changes in Omax, assessed using the Alcohol Purchase Task. Omax reflects the highest total amount in dollars that a participant would spend on alcohol-containing beverages. Values represent difference scores derived from log-transformed Omax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Alcohol Demand: Pmax
Time Frame: 48 hours after exercise
Changes in Pmax, assessed using the Alcohol Purchase Task. Pmax reflects the price point at which demand for alcohol becomes elastic (i.e., declines in response to increasing price). Values represent difference scores derived from log-transformed Pmax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Alcohol Demand: Essential Value
Time Frame: 48 hours after exercise
Changes in Essential Value, assessed using the Alcohol Purchase Task. Essential Value represents the reinforcing efficacy of alcohol, such that higher Essential Value indicates greater reinforcing efficacy. Values represent difference scores derived from Essential Values coded so that positive numbers indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Cannabis Demand: Intensity
Time Frame: 48 hours after exercise
Changes in intensity of cannabis demand, assessed using the Marijuana Purchase Task. Intensity reflects the number of joints that would hypothetically be consumed if they were free. Values represent difference scores derived from log-transformed intensity values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Cannabis Demand: Breakpoint
Time Frame: 48 hours after exercise
Changes in breakpoint of cannabis demand, assessed using the Marijuana Purchase Task. Breakpoint indicates the joint price at which participants report no cannabis consumption. Values represent difference scores derived from breakpoint values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Cannabis Demand: Omax
Time Frame: 48 hours after exercise
Changes in Omax, assessed using the Marijuana Purchase Task. Omax reflects the highest total amount that a participant would spend on cannabis. Values represent difference scores derived from log-transformed Omax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Cannabis Demand: Pmax
Time Frame: 48 hours after exercise
Changes in Pmax, assessed using the Marijuana Purchase Task. Pmax reflects the price point at which demand for cannabis becomes elastic (i.e., declines in response to increasing price). Values represent difference scores derived from log-transformed Pmax values coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Cannabis Demand: Essential Value
Time Frame: 48 hours after exercise
Changes in Essential Value, assessed using the Marijuana Purchase Task. Essential Value represents the reinforcing efficacy of cannabis, such that higher Essential Value indicates greater reinforcing efficacy. Values represent difference scores derived from Essential Values coded so that positive numbers indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise
Alcohol Demand: Intensity
Time Frame: 48 hours after exercise
Changes in intensity of alcohol demand, assessed using the Alcohol Purchase Task. Intensity reflects the number of drinks that would hypothetically be consumed if they were free. Values represent difference scores derived from log-transformed number of drinks coded so that positive values indicate an increase in the demand index from baseline to follow-up.
48 hours after exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 28, 2020

Primary Completion (Actual)

May 10, 2022

Study Completion (Actual)

May 10, 2022

Study Registration Dates

First Submitted

March 9, 2021

First Submitted That Met QC Criteria

March 9, 2021

First Posted (Actual)

March 10, 2021

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 5, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IRB202000058-N
  • 1F31AA028696-01A1 (U.S. NIH Grant/Contract)
  • AGR DTD 02-17-2020 (Other Grant/Funding Number: Research Society on Alcoholism)
  • UFCAREDAG002 (Other Grant/Funding Number: UF Center for Addiction Research and Education)
  • 00045887 (Other Grant/Funding Number: UF Dept of Clinical and Health Psychology)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Eccentric Biceps Flexion

3
Subscribe